$SLS News Article - SELLAS Life Sciences to Presen
Post# of 88
(Total Views: 142)
Posted On: 10/17/2023 8:55:46 AM
$SLS News Article - SELLAS Life Sciences to Present Final Data from Phase 1/2 Study of Galinpepimut-S in Combination with Keytruda (pembrolizumab) in Patients with WT1+ Platinum-Resistant Advanced Ovarian Cancer at the International Gynecologic Cancer Society 2023 Annu https://marketwirenews.com/news-releases/sell...88280.html
(0)
(0)SELLAS Life Sciences Group, Inc. (SLS) Stock Research Links
My Twitter: WhyteStocks
Scroll down for more posts ▼